Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
ConclusionsFavorable effectiveness and safety profile of taxanes following second-line nivolumab was observed in Japanese patients with advanced esophageal squamous cell carcinoma. When a patient with advanced esophageal squamous cell carcinoma receiving nivolumab becomes refractory or intolerant, subsequent taxane treatment may be a promising option.
Source: Esophagus - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Docetaxel | Esophagus Cancer | Gastroenterology | Japan Health | Skin Cancer | Squamous Cell Carcinoma | Study | Taxotere